Creed Francis, Morgan Richard, Fiddler Magdalen, Marshall Sarah, Guthrie Else, House Allan
Psychological Medicine Research Group, University of Manchester, United Kingdom.
Psychosomatics. 2002 Jul-Aug;43(4):302-9. doi: 10.1176/appi.psy.43.4.302.
Two hundred sixty-three consecutive medical inpatients were studied to assess whether depression and anxiety are associated with increased costs and reduced health-related quality of life. Seventy-three (27.8%) had depressive/anxiety disorders, 107 were "subthreshold" cases, and 83 were controls. After adjustment for severity of physical illness, using the Duke Severity of Illness Scale, cases and subthreshold cases incurred greater mean health care costs than controls over the follow-up period: $8,541 (SE = $605) versus $5,857 (SE = $859), P = 0.012. There was significant impairment of health-related quality of life (SF36 scores) in cases and, to a lesser extent, in subthreshold cases compared to controls. This impairment persisted at follow-up, as did anxiety and depression, indicating the need for future intervention studies.
对263名连续入住的内科患者进行了研究,以评估抑郁和焦虑是否与费用增加及健康相关生活质量下降有关。73名(27.8%)患有抑郁/焦虑障碍,107名是“亚阈值”病例,83名是对照组。使用杜克疾病严重程度量表对躯体疾病严重程度进行校正后,在随访期间,病例组和亚阈值病例组的平均医疗费用高于对照组:8541美元(标准误=605美元)对5857美元(标准误=859美元),P=0.012。与对照组相比,病例组的健康相关生活质量(SF36评分)有显著损害,亚阈值病例组的损害程度较轻。这种损害在随访时持续存在,焦虑和抑郁也是如此,这表明未来需要进行干预研究。